Vimarsana
Biggest News Aggregation in the World

Ucleoside Analog News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ucleoside Analog. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ucleoside Analog Today - Breaking & Trending Today

Vitamin D Counters Bone Density Loss With Aromatase Inhibitors - Vimarsana News

Vitamin D Counters Bone Density Loss With Aromatase Inhibitors

Among women with breast cancer being treated with aromatase inhibitors, supplementation with vitamin D and calcium protected against bone loss after 5 years.

Abrocitinib Approved for Atopic Dermatitis in Europe - Vimarsana News

Abrocitinib Approved for Atopic Dermatitis in Europe

The oral JAK inhibitor was approved for treating AD earlier in 2021 for treating AD in the United Kingdom, Japan, and Korea, and is under review at the US Food and Drug Administration.

Guselkumab Deemed Effective for PsA Previously Treated With TNFi - Vimarsana News

Guselkumab Deemed Effective for PsA Previously Treated With TNFi

COSMOS trial results in patients with psoriatic arthritis fit with the expectation that "people who've previously failed a TNF inhibitor might be a little less likely to respond to guselkumab."

Daily Oral PCSK9 Inhibitor Encouraging in Phase 1 Trials - Vimarsana News

Daily Oral PCSK9 Inhibitor Encouraging in Phase 1 Trials

What if the cholesterol-crushing efficacy of current PCSK9 inhibitors came in a pill instead of a syringe? That's one possibility for a Merck agent in the earliest stages of human trials.

When to Treat as Important as Which Drug to Use in WM - Vimarsana News

When to Treat as Important as Which Drug to Use in WM

When to initiate treatment for patients newly diagnosed with Waldenstrom macroglobulinemia (WM) is as important as which drug to use, says expert.